Mecure Industries PLC (NGX:MECURE)

Nigeria flag Nigeria · Delayed Price · Currency is NGN
61.50
0.00 (0.00%)
At close: Mar 23, 2026
Market Cap246.00B +390.0%
Revenue (ttm)77.69B +68.8%
Net Income6.46B +177.5%
EPS1.62 +177.5%
Shares Out4.00B
PE Ratio38.07
Forward PEn/a
Dividend0.32 (0.52%)
Ex-Dividend DateApr 24, 2026
Volume249,451
Average Volume310,481
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Range11.10 - 104.00
Beta1.04
RSI10.42
Earnings DateFeb 26, 2026

About Mecure Industries

Mecure Industries PLC manufactures and sells pharmaceuticals in Nigeria. The company engages in distributing multivitamins products. It also offers antibiotics, antimalarials, antihypertensives, antidiabetics, analgesics and nsaids, proton pump inhibitors, and H2 receptor antagonists. In addition, the company provides blood tonics; cough, cold, and catarrh preparations; antihistamines; anthelmintic; antacids; steroids; antispasmodics; and antidiarrheals. Further, it is involved in the contract manufacturing services. It sells its products throu... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 195
Stock Exchange Nigerian Stock Exchange
Ticker Symbol MECURE
Full Company Profile

Financial Performance

In 2025, Mecure Industries's revenue was 77.69 billion, an increase of 68.80% compared to the previous year's 46.03 billion. Earnings were 6.46 billion, an increase of 177.52%.

Financial Statements